I have MS primary and peripheral neuropathy secondary and I know of something that can help your Multiple
Sclerosis symptoms.  Permanently and positively help you for just $30 a month.  No I'm not selling it, the $30 a month
goes to anyone that you purchase the supplement from.  That’s all it costs to help repair the nerve damage of MS.  
So, you say, “If that’s true, why didn’t my doctor tell me to take the supplement?”  Doctors prescribe medicine based
on what is sold to them.  Doctors are inundated with ads for various drugs by billion-dollar drug companies.  These
billion-dollar companies have lots of research to back up the effectiveness of their drugs.  Usually it is the company
who pays for the research.  Who is  promoting this $30 a month supplement?  Besides me,  medical literature, a few
web sites and lots of vitamin retailers-no one.  If a doctor doesn’t read the right literature, how are they to know
about this supplement?  There's so much for doctors to keep up with that it’s not surprising that this supplement is
not well known.


I first read about it in "Neurology News," an ezine (electronic magazine) for physicians that's available to anyone on
the web.  That's right, the information is there for everyone.   I subscribed to it four years ago so I could keep up with
the newest treatments for MS and PN (Peripheral Neuropathy).  

Quite honestly, the PN bothered me more than the MS because the nerve damage in my feet caused severe pain.  I
read an abstract about Alpha Lipoic Acid (ALA) and how it helped those with Diabetic Neuropathy.  Since Diabetic
Neuropathy is caused by a demylination of the nerves and the symptoms of MS is caused by demylination of the
nerves, I decided to try it for the nerve damage in my feet.  


So I started taking a therapeudic dosage of ALA in an attempt to lessen the pain and numbness in my feet.  Three
months after starting a theraputic dosage of ALA, I realized that my cognitive abilities had changed - for the good.  I
didn't even know I had cognitive problems until I suddenly got better.* (See below.)  Was I surprised!  I took an IQ
test on the internet and found I scored the same as in high school.  I was back!  It took several more months of
therapy with ALA to get any changes in the nerves in my feet.  In all my reading I had read of nothing that could heal
the nerve damage caused by MS.  I quizzed my neurologist and of course she was skeptical but agreed that the logic
was there.  Of course, she said don't stop your MS therapy and I agreed.  The MS therapy stops the further
demylination of your nerves by, hopefully, stopping further relapses.  I am proposing that you try ALA therapy in
addition to your ABC MS therapy to help heal your already existing nerve damage.  It's cheap, safe and can positively
help you heal naturally.   


There is research to support my theory that ALA helps to heal nerve damage caused by MS.  One report says that
"oxidative injury may be important to the pathogenesis of multiple sclerosis."
(6) Since ALA is an antioxidant, it heals
oxidative injury.   According to another research study, the attack of the myelin by the immune system triggers the
production of reactive oxygen species. Lipoic Acid is a non-specific scavenger of reactive oxygen species.  It
decreases the effect of the immune system's attack of the myelin.
(4)  Another study indicated that Alpha-Lipoic Acid
"can effectively interfere with the autoimmune reaction associated with experimental autoimmune encephalomyelitis
(EAE) through mechanisms other than its antioxidant activity and supports further studies on the use of Alpha-Lipoic
Acid as a potential therapy for MS."
(5)  In a preliminary study, the spinal columns "of ALA-treated mice had reduced
demyelination and axonal loss and a rapid reduction in CD3+ T cells."
(6)  A Dr. Dennis Bourdette in Oregon is actually
studying the effectiveness of ALA for helping MS.  It was probably hard to get funding for a study of a substance
that is cheap and readily available.   The study is called "Natural Antioxidants in the Treatment of Multiple Sclerosis."  
Results of the second phase of the trial should be posted soon at the  National Center for Complementary and
Alternative Medicine web site.  The trial on ALA closed 7/30/04.

"Cognitive performance of relapsing remitting multiple sclerosis  patients was deficient when tasks required higher-order
working memory processes (Word List Generation, 10/36 Spatial Recall Test, Symbol Digit Modalities Test).  Primary progressive
MS and secondary progressive MS patients performed poorer than control subjects on all tasks.  Secondary progressive MS
patients performed more poorly than secondary progressive MS patients when tasks required higher-order working memory
processes, except when speed of information processing played a relatively important role (Symbol Digit Modalities Test, Paced
Auditory Serial Addition Test).  Whereas elapsing remitting MS patients generally performed better than the progressive subtypes,
they showed relatively poor verbal fluency."

Information that is provided in this site is not intended as a substitute for the medical advice of physicians.